After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Explore various ways to sell your expertise and turn your knowledge into cash. Start leveraging your skills to increase your income today.
17,344 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
GE Vernova surprised investors with strong momentum in the first half of 2026. This article breaks down what powered ...
SpaceX stunned markets with a massive IPO haul and a rapid follow-up bond issue. This article breaks down what happen...
A wave of forgotten 401K plans now totals roughly 31.9 million accounts worth about $2.1 trillion, highlighting a stu...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
A dedicated pure-miner uranium fund has jumped 61% this year, outpacing broader uranium plays. Analysts say the move ...
Boise remains a retirement magnet, but costs have risen. With a $900K pot, a paid-off home, and careful tax and cash-...
Micron unveils a historic plan to expand memory fabrication in the United States, led by CEO Sanjay Mehrotra. The mov...
When new Berkshire leadership takes the reins, investors wonder which names could ride along. Here’s why a flavor-foc...
Investors are weighing two value plays: VLUE leans on the value factor itself, while VTV sticks with mega-cap, discou...
The U.S. Treasury has designated SPYM as the default ETF for newborn accounts, depositing a $1,000 contribution into ...
Tesla pushed out a solid delivery quarter, but the stock didn’t follow. This article breaks down what the numbers mea...